Mark Levitt

Teknisk/Vetenskaplig/F&U Direktör på REDHILL BIOPHARMA LTD.

Health Technology

Health Services

Profil

Mark L.
Levitt is currently Director at EnGeneIC Pty Ltd. and Chief Scientific Officer at RedHill Biopharma Ltd. since 2017.
Formerly, Dr. Levitt was Director at UPMC Cancer Institute and Head of the Lung Cancer Unit at Sheba Medical Center.

Aktiva positioner av Mark Levitt

Företag	Position	Start
REDHILL BIOPHARMA LTD.	Teknisk/Vetenskaplig/F&U Direktör	2017-01-01
EnGeneIC Pty Ltd. EnGeneIC Pty Ltd. BiotechnologyHealth Technology Develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer	Direktör/Styrelseledamot	-

Alla aktiva positioner av Mark Levitt

Tidigare kända positioner av Mark Levitt

Företag	Position	Slut
UPMC Cancer Institute UPMC Cancer Institute Medical/Nursing ServicesHealth Services Provides health care and insurance services	Direktör/Styrelseledamot	-
Sheba Medical Center Sheba Medical Center Hospital/Nursing ManagementHealth Services Operates as a hospital	Företagsledare/Principal	-

Se detaljerna i Mark Levitts erfarenhet

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Mark Levitts erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	4
EnGeneIC Pty Ltd. EnGeneIC Pty Ltd. BiotechnologyHealth Technology Develops and commercializes novel concepts for the targeted delivery of drugs and other therapeutic molecules used in the treatment of cancer	Health Technology
Sheba Medical Center Sheba Medical Center Hospital/Nursing ManagementHealth Services Operates as a hospital	Health Services
UPMC Cancer Institute UPMC Cancer Institute Medical/Nursing ServicesHealth Services Provides health care and insurance services	Health Services
RedHill Biopharma Ltd. RedHill Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides GI, infectious diseases, medical countermeasures and oncology services	Health Technology